Trust & standards
Peptide Authority policies
Every public policy that governs what Peptide Authority publishes, who reviews it, how commercial relationships are disclosed, and what we will not publish under any circumstances. The new policy pages sit at the top; longstanding trust pages follow underneath.
Editorial & commercial policies
Named author policy
When pages carry a personal byline vs the editorial-team byline, and what each represents.
Reviewer credential policy
How we verify reviewer credentials, what specialties review what, what review certifies.
Medical review limitations
What medical review covers — regulatory accuracy and evidence presentation — and what it explicitly does not: personal clinical applicability.
Affiliate disclosure
The single Peptide Barn affiliate placement, where it appears, the full list of affiliate-free pages.
Advertising policy
No display ads, no sponsored content; what we would never run; what the threshold would be if we ever introduced sponsorship.
High-risk content policy
Content categories we will not publish — dosing, sourcing, supplier ranks — and categories that trigger extra reviewer check.
Data sources
The primary sources we cite (HMR 2012, NICE, MHRA, NHS, PubMed, ClinicalTrials.gov, WADA, CAP/ASA) and what we never cite as evidence.
No dosing, no sourcing
Why we don't publish doses, reconstitution recipes, or supplier ranks — and what we publish instead.
How to use this site safely
Consumer-facing guide to evidence grades, UK-status pills, contradictions, and when to call NHS 111 or 999.
Regulatory update log
Chronological log of MHRA / NICE / EMA / WADA actions affecting peptide and GLP-1 medicines that prompted content updates.
Evidence update log
Live count of peptide profiles and symptom guides with fully-seeded Evidence Standards data, sorted by last review date.
Correction log
Public log of corrections published to the site since 2026-05-20. Open and inspectable.
Existing trust pages
These pages predate the policies namespace and remain at their original URLs. They are linked from the new policy pages where relevant.
Editorial Standards
Evidence hierarchy, claim grading, source quality, review cadence, editorial firewall.
Editorial Board
Named reviewers with institutional affiliations and credentials.
Corrections Policy
How errors are reported, reviewed, and published.
Conflict of Interest Policy
What commercial relationships we do and do not have.
We Are Not A Peptide Retailer
Plain-language statement of the editorial position on retail, affiliate, and clinic relationships.
Evidence Grading Methodology
The A-E (plus R and S) evidence grading system explained.
UK Regulatory Methodology
How we approach UK regulatory framing — HMR 2012, MHRA, NICE, ASA/CAP.
Medical Disclaimer
Full site-wide medical disclaimer.
Community safety policy
Forum-specific safety rules for user-generated content.
Community moderation policy
How forum content is moderated and what triggers action.
Spotted a policy that's missing or one that doesn't match what the site actually does? Tell us via the corrections process. Policy drift is a real failure mode and we treat it as one.